rs781364428
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000232.5(SGCB):c.23_24insAGCGGCGGCGGCGGC(p.Ala5_Ala9dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000664 in 150,690 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000044 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
SGCB
NM_000232.5 inframe_insertion
NM_000232.5 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.16
Genes affected
SGCB (HGNC:10806): (sarcoglycan beta) This gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCB | NM_000232.5 | c.23_24insAGCGGCGGCGGCGGC | p.Ala5_Ala9dup | inframe_insertion | 1/6 | ENST00000381431.10 | NP_000223.1 | |
SGCB | XM_047416074.1 | c.23_24insAGCGGCGGCGGCGGC | p.Ala5_Ala9dup | inframe_insertion | 1/5 | XP_047272030.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGCB | ENST00000381431.10 | c.23_24insAGCGGCGGCGGCGGC | p.Ala5_Ala9dup | inframe_insertion | 1/6 | 1 | NM_000232.5 | ENSP00000370839 | P1 | |
SGCB | ENST00000506357.5 | c.9_10insAGCGGCGGCGGCGGC | p.Ala5_Glu6insAlaAlaAlaAlaAla | inframe_insertion, NMD_transcript_variant | 1/5 | 5 | ENSP00000421235 |
Frequencies
GnomAD3 genomes AF: 0.00000664 AC: 1AN: 150690Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
1
AN:
150690
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000440 AC: 5AN: 1135466Hom.: 0 Cov.: 31 AF XY: 0.00000547 AC XY: 3AN XY: 548178
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
5
AN:
1135466
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
548178
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000664 AC: 1AN: 150690Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73560
GnomAD4 genome
AF:
AC:
1
AN:
150690
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
73560
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2E Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 09, 2022 | This variant, c.9_23dup, results in the insertion of 5 amino acid(s) of the SGCB protein (p.Ala5_Ala9dup), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SGCB-related conditions. ClinVar contains an entry for this variant (Variation ID: 551330). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Apr 04, 2017 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 29, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at